Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-09-05
2006-09-05
Campell, Bruce R. (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
Reexamination Certificate
active
07101844
ABSTRACT:
The present invention relates to a cytoplasmic transduction peptide (CTP) showing transduction potential, as well as cytoplasmic remaining potential and various uses thereof. The CTP of this invention exhibits a transduction potential identical or higher than the conventional protein transduction, PTD, and a strong tendency to remain in the cytoplasm, so that it is very useful in inducing cytotoxic T lymphocytes (CTL) and a drug delivery system (DDS) targeting cytoplasm.
REFERENCES:
patent: 5807746 (1998-09-01), Lin et al.
patent: 6043339 (2000-03-01), Lin et al.
patent: 95/28494 (1995-10-01), None
patent: 95/34665 (1995-12-01), None
patent: 00/34308 (2000-06-01), None
Wouters-Tyrou, et al., (J. Biol. Chem. 1991, 266, 17388-95.
Wender et al; “The Design, Synthesis, and Evaluation of Molecules that Enable or Enhance Cellular Uptake: Peptoid Molecular Transporters”; ;PNAS, Nov. 2000, vol. 97, No. 24, pp. 13003-13008.
Schwarze et al; “In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the Mouse”; Science, vol. 285, Sep. 3, 1999, pp. 1569-1572.
Ho et al; “Synthetic Protein Transduction Domains: Enhanced Transduction Potential in Vitro and in Vivo”; Cancer Research 61, Jan. 15, 2001, pp. 474-477.
Ford et al; “Protein Transduction: an Alterative to Genetic Invention?”; Gene Ther., Jan. 2001, vol. 8, No. 1, pp. 1-4.
Vocero-Akbani et al; “Transduction of Full-Length Tat Fusion Proteins Directly into Mammalian Cells: Analysis of T Cell Receptor Activation-Induced Cell Death”; Methods Enzymol., 2000, vol. 322, pp. 508-521.
Bae Yong-Soo
Choi In-Soo
Jeon Choon-Ju
Kim Chang-Hyun
Kim Dae-You
Campell Bruce R.
Creagene, Inc.
Gudibande Satyanarayana R.
Nixon & Vanderhye P.C.
LandOfFree
Cytoplasmic transduction peptides and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cytoplasmic transduction peptides and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cytoplasmic transduction peptides and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3538815